A study provides new insight into how damaged cells interact within disease-promoting microenvironments following acute kidney injury, or AKI. Researchers used a cutting-edge tool, called seqFISH, ...
Scientists have announced that, in tests to develop multifunctional kidney tissue, young stem-cell populations showed ...
The nonsteroidal mineralocorticoid receptor antagonist finerenone has been reported to improve kidney and cardiovascular outcomes in persons with type 2 diabetes and chronic kidney disease (CKD).
Associate Professor in Microvascular Medicine, Rebecca Foster, explores therapeutic approaches to improve kidney health for ...